Abstract
Medication error forms a major proportion of the errors in the medical system. Despite many studies of adverse drug events, there are no systematic ways of ensuring safety, or of assessing how safe a pharmaceutical system is. Risk assessment is required in hazardous industries such as nuclear power or oil and gas. Risk assessments involve identifying the defences and assessing their effectiveness and are relatively uncommon in clinical pharmacy , as opposed to reactive approaches involving incident analyses. Risk factors, that degrade barriers, can be identified and their effect measured. A risk assessment structure for pharmacy processes is proposed that can also be used to support incident investigation and analysis processes and provide a standard for audit.
This is a preview of subscription content, log in via an institution to check access.
References
Kohn L, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Committee on Quality of Health Care in America; Institute of Medicine. National Academy Press: Washington, DC, 2000.
Audit Commission, A spoonful of sugar. Medicines management in NHS hospitals. London: Audit Commission, 2001.
NRC Handelsblad, 1 May 2001.
Medication Safety Task Force, 2001.
Phillips DP, Christenfeld N, Glynn LM. Increase in US medication-error deaths between 1983 and 1993. Lancet 1998; 351: 643–4.
Bogner MS, Human error in medicine. Hillsdale, New Jersey: Lawrence Erlbaum, 1994.
Vincent C, Taylor-Adams S, Stanhope N. Framework for analysing risk and safety in clinical medicine. BMJ 1998; 316: 1154–7.
Senders J. Medical devices, medical errors and medical accidents. In M. Bogner, editor, Medical error. Hillsdale, New Jersey: Lawrence Erlbaum, 1994
Van Cott H. Human errors: their causes and reduction. In M. Bogner, editor, Medical error. Hillsdale, New Jersey: Lawrence Erlbaum, 1994.
Bernstein PL. Against the gods: the remarkable story of risk. New York: John Wiley & Sons, 1996.
Berwick DM. Not again! BMJ 2001; 322: 247–8.
Bickford Smith PJ. Designing safer medical devices requires financial and medical support. BMJ 2001; 322: 548.
Seal JRC. Erroneous intrathecal injections result from a problem with protocols. BMJ 2001; 322: 548.
Cook RI. Combatting medical errors - letter in reply. Lancet 2000; 356: 167.
Kelly WN. Potential risks and prevention, part 1: fatal adverse drug events. Am J Health Syst Pharm 2001; 58: 1317–24
Phillips J, Beam S, Brinker A, Holquist C, Honig P, Lee LY, Pamer C. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 1835–41.
Kelly WN. Potential risks and prevention, part 2: druginduced permanent disabilities. Am J Health Syst Pharm 2001; 58: 1325–9
Reason JT, Carthey J, de Leval MR. Diagnosing 'Vulnerable System Syndrome': a prerequisite to effective risk management. Qual Health Care 2000; 10: 21–5.
Reason JT. Human error. Cambridge: Cambridge University Press, 1990.
Reason JT. Managing the risks of organisational accidents. Aldershot, UK: Ashgate, 1997.
Turner B. Man-made disasters. Oxford: Wykeham, 1978.
Wagenaar WA, Groeneweg J. 100 Accidents at sea - multiple causes and impossible consequences. Int J Man Machine Studies 1987; 27: 587–98.
Wagenaar J, Groeneweg J, Hudson PTW, Reason JT. Safety in the oil industry. Ergonomics 1994; 37: 1999–2013.
Reason JT, Shotton R, Wagenaar WA, Groeneweg J, Hudson PTW. Tripod - a principled approach to safety. Leiden University, Report for Shell International Exploration and Production, 1987.
Maurino D, Reason JT, Johnstoen N, Lee R. Beyond aviation human factors. Aldershot, UK: Ashgate, 1995.
Reason J. Human error: models and management. BMJ 2000; 320: 768–70.
Hudson PTW, Reason JT, Wagenaar WA, Bentley PD, Primrose M, Visser JP. Tripod Delta: proactive approach to enhanced safety. J Petroleum Technol 1994; 46: 58–62.
vd Graaf, GC, Milne D, Primrose M. HSE cases - some lessons learned. Exploration and Production Newsletter. Shell International, 1996.
Cullen The Hon Lord D. The public inquiry into the Piper Alpha disaster. 2 Vols. London: HMSO, 1990.
Tutuarima JA, Linskens ME, de Wit APM, Taat CW, de Haan RJ, Bossuyt PPM. Zuster, dokter of patient - incidentie en preventie van medicatiefouten in het AMC; een foutenanalyse. [Nurse, doctor or patient - incidence and prevention of medication errors in the AMC; an error analysis.] Internal Report, Amsterdam Medical Centre, 1995.
Dean D, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital in-patients: a prospective study Lancet 2002; 359: 1373–8
Hudson PTW, Verschuur WLG, Lawton R, Parker D, Reason JT. Bending the rules II - the violation manual. Centre for Safety Science, Leiden University, 1997.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hudson, P., Guchelaar, HJ. Risk assessment in clinical pharmacy. Pharm World Sci 25, 98–103 (2003). https://doi.org/10.1023/A:1024068817085
Issue Date:
DOI: https://doi.org/10.1023/A:1024068817085